Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population-Reference-Cited by-同舟云学术

Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population

Published:2003-08-01 Issue:4 Volume:59 Page:303-312
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:
Short-container-title:European Journal of Clinical Pharmacology

Author:

Gaikovitch Elena A.,Cascorbi Ingolf,Mrozikiewicz Przemyslaw M.,Brockm�ller J�rgen,Fr�tschl Roland,K�pke Karla,Gerloff Thomas,Chernov Jury N.,Roots Ivar

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00228-003-0606-2.pdf

Cited by 195 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ASSOCIATION OF RS1495741 POLYMORPHISM OF THE NAT2 GENE AND THE RISK OF DEVELOPMENT OF INFLAMMATORY LIVER DISEASES UNDER EXPOSURE TO EXTERNAL FACTORS;YAKUT MED J;2024

2. An introduction to personalized medicine;Therapeutic Drug Monitoring;2024

3. Role of genetic polymorphisms in clopidogrel response variability: a systematic review;Open Heart;2023-11

4. Genogeografiya farmakogeneticheski znachimyh DNK-markerov CYP2C19 supersemejstva citohromov v narodonaselenii Rossii i sopredel'nyh stran;Вестник Российского государственного медицинского университета;2023-10

5. Gene geography of pharmacogenetically significant CYP2C19 cytochrome superfamily DNA markers in the populations of Russia and neighboring countries;Bulletin of Russian State Medical University;2023-10